Jefford Michael, Moore Rosemary
Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, VIC, Australia. Michael.Jeff
Lancet Oncol. 2008 May;9(5):485-93. doi: 10.1016/S1470-2045(08)70128-1.
Guidelines on informed consent intend to protect patients and promote ethical research conduct. To give informed consent, individuals should understand the purpose, process, risks, benefits, and alternatives to research (or a proposed clinical intervention) and make a free, voluntary decision about whether to participate. Many participants have incomplete understanding of various features of clinical trials. Issues associated with the length, format, and language of documents for written informed consent are common. Here, we analyse the written consent form, particularly in the context of clinical research, and the discussions that take place between clinician or investigator and patient. We review strategies to improve consent forms, particularly the use of plain language. Recommendations are made on discussions between investigator and patient to improve participant comprehension and satisfaction with the informed-consent process.
知情同意指南旨在保护患者并促进符合伦理的研究行为。为了给予知情同意,个人应了解研究(或拟议的临床干预)的目的、过程、风险、益处和替代方案,并就是否参与做出自由、自愿的决定。许多参与者对临床试验的各种特征理解不完整。与书面知情同意文件的长度、格式和语言相关的问题很常见。在此,我们分析书面同意书,特别是在临床研究背景下的书面同意书,以及临床医生或研究者与患者之间进行的讨论。我们回顾了改进同意书的策略,尤其是使用通俗易懂的语言。就研究者与患者之间的讨论提出了建议,以提高参与者对知情同意过程的理解和满意度。